What is the share price of Venkat Pharma Ltd (532093)?

Company share prices are keep on changing according to the market conditions. The current trading price of Venkat Pharma Ltd (532093) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Venkat Pharma?

The latest standalone P/E ratio of Venkat Pharma as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Venkat Pharma Ltd (532093)?

The latest standalone P/B ratio of Venkat Pharma Ltd (532093) as of 01-Jan-1970 is -0.66.

What is the 52-week high and low of Venkat Pharma Ltd (532093)?

The 52-week high of Venkat Pharma Ltd (532093) is Rs. 3.72 and the 52-week low is Rs. 3.40.

Venkat Pharma Ltd (532093) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Venkat Pharma Ltd (532093)
Brand: Venkat Pharma

Venkat Pharma Ltd (532093)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532093 NSE: Pharmaceuticals & Drugs | Small Cap | Venkat Pharma Share Price

Venkat Pharma Ltd (532093)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532093 NSE: Pharmaceuticals & Drugs | Small Cap | Venkat Pharma Share Price

Key Metrics

Valuation Multiples

Market Cap

₹2 Cr.

Current Price

₹0

52-Week Low / High

₹3 / 4

TTM EPS

₹-0.1

TTM Sales

₹0 Cr.

Book Value per Share

₹-5.2

P/E Ratio

0.00

Industry PE

49.8

Price to Book (P/B)

-0.66

Price to Sales (P/S)

0.00

EV/EBITDA

-774.29

Dividend Yield

NAN%

Profitability Efficiency

Return on Equity (ROE)

0.00%

Return on Capital Employed (ROCE)

-0.26%

Return on Assets (ROA)

-0.25%

Operating Profit Margin

Net Profit Margin

Gross Profit Margin

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

22.35%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹-8 Cr.

Equity

₹5 Cr.

Face Value

₹10

All Time Low / High

₹1.39 / 66.80

Venkat Pharma stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'10	Mar'11	Mar'12	Mar'13	TTM
ROCE % ⓘ	5.6%	2.2%	7.2%	0%	7.8%	10.2%	-1.5%	-0.5%	-0.2%	-0.3%	-
Growth Parameters ⓘ
Sales ⓘ	19.7	41.7	51.9	0	47.8	36.4	0	0	0	0	0
Sales YoY Gr.	-	111.5%	24.5%	-100%	NA	-23.9%	-100%	NA	NA	NA	-
Adj EPS ⓘ	0.2	0.1	0.9	0	0.4	0.5	-0.5	-0.1	-0.1	-0.1	-0.1
YoY Gr.	-	-50%	1075%	-100%	NA	14.3%	-206.3%	NA	NA	NA	-
BVPS (₹) ⓘ	10.7	10.8	11.8	0	14.6	15.1	-4.8	-4.9	-5	-5.1	-5.2
Adj Net Profit ⓘ	0.1	0	0.3	0	0.2	0.2	-0.3	-0.1	-0	-0	-0
Cash Flow from Ops. ⓘ	0.9	-0.8	0.3	0	-1.5	0.3	-0	-0	-0	-0	-
Debt/CF from Ops. ⓘ	2.7	-2.7	6.5	0	-4.7	43.9	-6228.5	-12457	-1536.2	-14785.4	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-100%	-100%	NA	NA
Adj EPS ⓘ	-193.8%	-173.5%	NA	NA
BVPSⓘ	-192.1%	-181%	NA	NA
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'00	Mar'01	Mar'02	Mar'04	Mar'05	Mar'10	Mar'11	Mar'12	Mar'13	TTM
Return on Equity % ⓘ	1.4	0.7	8	3.5	3.2	-11.2	2.7	1.5	1.8	1
Op. Profit Mgn % ⓘ	2.7	0.7	1.2	2	5.3	0	0	0	0	NAN
Net Profit Mgn % ⓘ	0.3	0.1	0.6	0.4	0.6	0	0	0	0	-INF
Debt to Equity ⓘ	0.7	0.6	0.5	1.1	1.8	-6.8	-6.6	-7.7	-7.6	3.8
Working Cap Days ⓘ	0	251	206	189	240	0	0	0	0	0
Cash Conv. Cycle ⓘ	0	46	46	80	162	0	0	0	0	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'04	Mar'05	Mar'10	Mar'11	Mar'12	Mar'13
Sales	19.71	41.68	51.90	47.83	36.42	0	0	0	0
Operating Expenses ⓘ +	19.18	41.39	51.30	46.89	34.50	0.21	0.04	0.02	0.03
Manufacturing Costs	0.37	37.61	42.15	5.69	5.36	0	0	0	0
Material Costs	17.35	-0.05	0.21	34.34	23.83	0	0	0	0
Employee Cost	0.13	0.13	0.79	0.45	0.54	0.02	0.02	0	0
Other Costs ⓘ	1.33	3.70	8.16	6.41	4.76	0.19	0.02	0.02	0.03
Operating Profit ⓘ	0.53	0.29	0.60	0.93	1.93	-0.21	-0.04	-0.02	-0.03
Operating Profit Margin (%)	2.7%	0.7%	1.1%	2.0%	5.3%	-	-	-	-
Other Income ⓘ +	0.04	0.13	0.13	0.02	0	0	0	0	0
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.28	0.08	0.05	0.43	1.37	0	0	0	0
Depreciation ⓘ	0.22	0.28	0.29	0.18	0.26	0.04	0.02	0.02	0.02
Profit Before Tax ⓘ	0.07	0.06	0.38	0.34	0.30	-0.24	-0.06	-0.04	-0.04
Tax ⓘ	0.01	0.03	0.05	0.15	0.08	0.01	0	0	0
Profit After Tax	0.05	0.03	0.33	0.19	0.22	-0.25	-0.06	-0.04	-0.04
PAT Margin (%)	0.3%	0.1%	0.6%	0.4%	0.6%	-	-	-	-
Adjusted EPS (₹)	0.2	0.1	0.9	0.4	0.5	-0.5	-0.1	-0.1	-0.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Venkat Pharma - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'04	Mar'05	Mar'10	Mar'11	Mar'12	Mar'13
Equity and Liabilities
Shareholders Fund +	3.90	3.92	4.25	6.68	6.89	-2.38	-2.44	-2.50	-2.54
Share Capital ⓘ	3.50	3.50	3.50	4.53	4.53	4.99	4.99	4.99	4.99
Reserves ⓘ	0.40	0.42	0.75	2.15	2.37	-7.36	-7.43	-7.48	-7.53
Debt +	2.52	2.09	1.96	7.10	12.13	16.19	16.19	19.20	19.22
Long Term Debt	2.52	2.09	1.96	7.10	12.13	16.19	16.19	19.20	19.20
Short Term Debt	0	0	0	0	0	0	0	0	0.02
Minority Interest	0	0	0	0	0	0	0	0	0
Trade Payables	21.89	23.54	19.85	5.95	2.51	4.08	4.08	0.53	0.53
Others Liabilities ⓘ	0.20	3.36	3.85	3.49	6.53	0.26	0.18	0.75	0.65
Total Liabilities ⓘ	28.50	32.91	29.92	23.21	28.06	18.16	18.01	17.99	17.87
Fixed Assets
Net Fixed Assets ⓘ +	1.81	1.92	1.80	1.57	1.42	0.92	0.89	0.87	0.85
Gross Block	2.86	3.26	3.43	3.66	3.73	3.72	3.72	3.71	3.71
Accumulated Depreciation	1.05	1.34	1.63	2.10	2.30	2.80	2.83	2.84	2.86
CWIP ⓘ	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	0
Inventories	1	1.04	0.84	2.20	7.09	2.14	2.14	2.14	2.02
Trade Receivables	25.38	28.84	26.78	17.20	14.79	12.74	12.73	12.73	12.73
Cash Equivalents	0.03	0.07	0.07	0.06	0.22	0.02	0.02	0.01	0.01
Others Assets ⓘ	0.29	1.04	0.44	2.18	4.54	2.35	2.24	2.25	2.25
Total Assets ⓘ	28.50	32.91	29.92	23.21	28.06	18.16	18.01	17.99	17.87

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'04	Mar'05	Mar'10	Mar'11	Mar'12	Mar'13
Cash Flow From Operating Activity ⓘ +	0.92	-0.78	0.30	-1.51	0.28	-0	-0	-0.01	-0
PBT ⓘ	0.07	0.23	0.38	0.33	0.30	-0.24	-0.06	-0.04	-0.04
Adjustment ⓘ	0.52	0.37	0.35	0.21	0.28	0.04	0.02	0.02	0.02
Changes in Working Capital ⓘ	0.62	-1.31	-0.39	-1.9	-0.19	0.21	0.04	0.01	0.03
Tax Paid ⓘ	0	0	0	-0.14	-0.11	-0.01	0	0	0
Cash Flow From Investing Activity ⓘ +	-0.52	0.39	-0.17	-0.09	-0.12	0	0.01	0.01	0
Capex	-0.52	0	-0.17	-0.09	-0.12	0	0.01	0.01	0
Net Investments	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0.39	0	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	-0.38	0.43	-0.13	1.03	0	0	0	0	0
Net Proceeds from Shares ⓘ	0	0	0	1.03	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-0.38	0.43	-0.13	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0
Net Cash Flow ⓘ	0.02	0.04	-0	-0.57	0.15	-0	0	-0.01	-0

Financial Ratio

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'04	Mar'05	Mar'10	Mar'11	Mar'12	Mar'13
Ratios
ROE (%)	1.45	0.74	8.29	3.55	3.24	N/A	N/A	N/A	N/A
ROCE (%)	5.57	2.23	7.16	7.77	10.2	N/A	N/A	N/A	N/A
Asset Turnover Ratio	0.69	1.36	1.65	1.8	1.42	0	0	0	0
PAT to CFO Conversion(x)	18.4	-26	0.91	-7.95	1.27	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	470.10	237.40	195.60	167.80	160.30	0	0	0	0
Inventory Days	18.40	8.90	6.60	11.60	46.50	0	0	0	0
Payable Days	460.50	0	0	137.10	64.80	0	0	0	0

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Venkat Pharma Ltd FAQs

The current trading price of Venkat Pharma on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Venkat Pharma stood at ₹1.70 Cr

The latest P/E ratio of Venkat Pharma as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Venkat Pharma as of 31-Dec-1969 is -0.66.

The 52-week high of Venkat Pharma is ₹3.72 and the 52-week low is ₹3.40.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Venkat Pharma is ₹0.00 ( Cr.) .

Data is not available for this company.

No data found

About Venkat Pharma Ltd

Venkat Pharma Ltd is a public limited company registered under the Indian Companies Act 1956 and their stock is listed in Bombay Stock Exchange (BSE) and is being actively traded. Established in 1989 it started manufacturing & sales of pharma products in 1992. The company is solely into the manufacturing and export of pharmaceutical products since their inception with an unswerving dedication.

At Venkat Pharma they meticulously manufacture pharma products, and constantly improvise existing product mix, thereby carving out a niche for themselves, in the global playing field of pharma.

Their philosophy is to provide value priced and quality pharmaceutical products to the humankind at large. At Venkat, they believe, that there is no compromise on the health of a human being. Their growth rate is quite above the industry CAGR growth rates as they are growing at a rate of 35% year on year.

Product range of the company includes:

API
PFIs
Finished Dosage
Under Development
Nutraceuticals

Milestones:

Floated as a Pvt. Ltd Company in 1989
Entered International Market in 1994
Became Public Ltd company in 1995
Issued an IPO in 1996
Listing in Bombay Stock Exchange in 1997
International market expansion via Product Registration Year 2000
Started APIs manufacturing in 2001
Strengthening of bottom line by trimming down less profitable products & markets in 2002
Expansions initiated in Regulated Markets

Achievements/ recognition :

It is an ISO 9001: 2000 certified organisation

Venkat Pharma Ltd (532093)

Venkat Pharma Ltd (532093)

Venkat Pharma stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Venkat Pharma - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Venkat Pharma Ltd FAQs

About Venkat Pharma Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Venkat Pharma Ltd (532093)

Venkat Pharma Ltd (532093)

Venkat Pharma stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Venkat Pharma - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Venkat Pharma Ltd FAQs

What is the share price of Venkat Pharma?

What is the market cap of Venkat Pharma?

What is the P/E ratio of Venkat Pharma?

What is the P/B ratio of Venkat Pharma?

What is the 52-week high and low of Venkat Pharma?

What is the TTM revenue of Venkat Pharma?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About Venkat Pharma Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.